Advertisement

Bijblijven

, Volume 23, Issue 4, pp 25–35 | Cite as

De ziekte van Bechterew (spondylitis ankylopoetica, SA)

  • R. Wittoek
  • H. Mielants
Artikel

Samenvatting

Spondylitis ankylopoetica (SA) (of ziekte van Bechterew) is een chronische inflammatoire aandoening van het axiale en perifere skelet die zich meestal manifesteert door rugpijn en toenemende stijfheid van de wervelkolom en aantasting van de perifere gewrichten, alsook extra-articulaire manifestaties. Kenmerkend is dat de ziekte jonge volwassenen treft in de tweede of derde levensdecade.

ziekte van Bechterew spondylitis ankylopoetica spondylartropathie uveitis inflammatoir darmlijden HLA B 27 biologicals 

Literatuur

  1. 1.
    Feldtkeller E, Khan M, Heijde D van der, Linden S van der, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003;23(2):61-6.Google Scholar
  2. 2.
    Rudwaleit M, Listing J, Brandt J, Braun J. Prediction of a major clinical response (BASDAI50) to tumour necrosis factor alfa blockers in ankylosing spondylitis. Ann Rheum Dis 2004;63:665-70.Google Scholar
  3. 3.
    Malleson P, Petty R. Clinical and therapeutic aspects of juvenile-onset spondyloarthropathies. Curr Opin Rheumatol 1997;9:291-4.Google Scholar
  4. 4.
    Maksymowitch W, Chou C, Russell A. Matching prevalence of peripheral arthritis and acute anterior uveitis in individuals with ankylosing spondylitis. Ann Rheum Dis 1995;54:128.Google Scholar
  5. 5.
    Mielants H, Veys E, Vos M de, Cuvelier C, Goemaere S, Clercq L de, et al. The evolution of spondylarthropathies in relation to gut histology I. Clinical aspects. J Rheumatol 1995;22:2266-72.Google Scholar
  6. 6.
    Smale S, Natt R, Orchard T, Russell A, Bjarnason I. Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum 2001;44:2728-36.Google Scholar
  7. 7.
    Mielants H, Veys E, Cuvelier C, Vos M de. Course of gut inflammation in spondylarthropathies and therapeutic consequences. Baillieres Clin Rheumatol 1996;10(1):147-64.Google Scholar
  8. 8.
    Keyser F de, Elewaut D, Vos M de, Vlam K de, Cuvelier C, Mielants H, et al. Bowel inflammation and the spondylarthropathies. Rheum Dis Clin North Am 1998;24:785-813, ix-x.Google Scholar
  9. 9.
    Brophy S, Pavy S, Lewis P, Taylor G, Bradbury L, Robertson D, et al. Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors. J Rheumatol 2001;28:2667-73.Google Scholar
  10. 10.
    Sun J, Khan M, Farhat A, Bahler R. Alterations in cardiac diastolic function in patients with ankylosing spondylitis. Int J Cardiol 1992;37:65-72.Google Scholar
  11. 11.
    Strobel E, Fritschka E. Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports. Clin Rheumatol 1998;17:524-30.Google Scholar
  12. 12.
    El Maghraoui A. Osteoporosis and ankylosing spondylitis. Joint Bone Spine 2004;71(4):291-5.Google Scholar
  13. 13.
    Cooper C, Carbone L, Michet C, Atkinson E, O’Fallon W, Melton 3rd L. Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol 1994;21:1877-82.Google Scholar
  14. 14.
    Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Stangel W, et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol 1988;15(7):1109-14.Google Scholar
  15. 15.
    Spoorenberg A, Heijde D van der, Klerk E de, Dougados M, Vlam K de, Mielants H, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 1999;26:980-4.Google Scholar
  16. 16.
    Braun J, Brandt J, Listing J, Zink A, Alten R, Krause A, et al. Treatment of active ankylosing spondylitis with infliximab – a double blind placebo controlled multicenter trial. Lancet 2002;359:1187-93.Google Scholar
  17. 17.
    Dougados M, Gueguen A, Nakache JP, Velicitat P, Zeidler H, Veys E, et al. Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol 1999;26:971-4.Google Scholar
  18. 18.
    Ruof J, Stucki G. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis. J Rheumatol 1999;26:966-70.Google Scholar
  19. 19.
    Taylor H, Wardle T, Beswick E, Dawes P. The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis. Br J Rheumatol 1991;30:330-5.Google Scholar
  20. 20.
    Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, et al. Prevalence of spondylarthropathies in HLA B27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67.Google Scholar
  21. 21.
    Braun J, Sieper J. Inception cohorts for spondylarthropathies. Z Rheumatol 2000;59:117-21.Google Scholar
  22. 22.
    Linden S van der, Valkenburg H, Jongh B de, Cats A. The risk of developing ankylosing spondylitis in HLA B27 positive individuals. A comparison of relatives of spondylitis patients with general population. Arthritis Rheum 1984;27:241-9.Google Scholar
  23. 23.
    Sieper J, Rudwaleit M. Concepts and epidemiology of spondylarthritis. Best Pract Res Clin Rheumatol 2006;20:593-9.Google Scholar
  24. 24.
    Lisdonk E van der. Persoonlijke mededeling. Nijmegen: CMR 2007.Google Scholar
  25. 25.
    Zink A, Braun J, Listing J, Wollenhaupt J. Disability and handicap in rheumatoid arthritis and ankylosing spondyitis – results from the German rheumatological database. J Rheumatol 2000;27:613-22.Google Scholar
  26. 26.
    Braunstein E, Martel W, Moidel R. Ankylosing spondylitis in men and women: a clinical and radiographic comparison. Radiology 1982;144:91-4.Google Scholar
  27. 27.
    Linden S van der, Valkenburg H, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-7.Google Scholar
  28. 28.
    Braun J, Sieper J, Bollow M. Imaging of sacroiliitis. Clin Rheumatol 2000;19:51-7.Google Scholar
  29. 29.
    Blum U, Buitrago-Tellez C, Mudinger A, Krause T, Lauenberger J, Vaith P, et al. Magnetic resonance imaging (MRI) for detection of active sacroiliitis – a prospective study comparing conventional radiography, scintigraphy and contrast enhanced MRI. J Rheumatol 1996;23:2107-15.Google Scholar
  30. 30.
    Rasker J, Prevo R, Lanting P. Spondylodiscitits in ankylosing spondylitis, inflammation or trauma? A description of six cases. Scand J Rheumatol 1996;25:52-7.Google Scholar
  31. 31.
    Zochling J, Heijde D van der, Burgos-Vargas R, Collantes E, Davis Jr. J, Dijkmans B, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006;65:442-52.Google Scholar
  32. 32.
    Dougados M, Behier J, Jolchine I, Calin A, Heijde D van der, Olivieri I, et al. Efficacy of celecoxib, a cylcooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum 2001;44(1):180-5.Google Scholar
  33. 33.
    Wanders A, Heijde D van der, Landewé R, Béhier JM, Calin A, Olivieri IR, et al. Nonsteroidal anti-inflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005;52(6):1756-65.Google Scholar
  34. 34.
    Peters N, Ejstrup L. Intravenous methylprednisolone pulse therapy in ankylosing spondylitis. Scan J Rheumatol 1992;21(3):134-8.Google Scholar
  35. 35.
    Clegg O. Treatment of ankylosing spondylitis. J Rheumatol 2006;33(S78):24-31.Google Scholar
  36. 36.
    Benitez-Del-Castillo J, Garcia-Sanchez J, Iradier T, Banares A. Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye 2000;14:340-3.Google Scholar
  37. 37.
    Keyser F de, Bosch F van den, Mielants H. Anti-TNF-alpha therapy in ankylosing spondylitis. Cytokine 2006;33:294-8.Google Scholar

Copyright information

© Bohn Stafleu van Loghum 2007

Authors and Affiliations

  • R. Wittoek
    • 1
  • H. Mielants
  1. 1.

Personalised recommendations